Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin

Amino Acids

Volumn 47, Issue 9, 2015, Pages 1983-1993

  Sitar, Mustafa Erinc ^a   Kayacelebi, Arslan Arinc ^a   Beckmann, Bibiana ^a   Kielstein, Jan T ^a   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anticoagulation; Coagulation; Erythrocytes; Haemodialysis; Mass spectrometry; Nitric oxide; Proteins

Indexed keywords

EDETIC ACID; HUMAN SERUM ALBUMIN; N(G),N(G) DIMETHYLARGININE; PARACETAMOL; SALICYLIC ACID; THERMOLYSIN; ARGININE; N,N-DIMETHYLARGININE; PROTEIN BINDING; SERUM ALBUMIN;

ACUTE KIDNEY FAILURE; AMINO ACID BLOOD LEVEL; ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BLOOD CLOTTING; CASE REPORT; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG PROTEIN BINDING; HEMODIALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SOLUBILITY; THERAPY EFFECT; ACUTE KIDNEY INJURY; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; CLINICAL TRIAL; CRITICAL ILLNESS; FEMALE; MALE; METABOLISM; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; ARGININE; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; PROTEIN BINDING; PROTEOLYSIS; RENAL DIALYSIS; SERUM ALBUMIN; THERMOLYSIN;

EID: 84940461793     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-1991-4     Document Type: Article

References (51)

1. Adekoya OA, Sylte I (2009) The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential. Chem Biol Drug Des 73:7-16
2. Araujo P (2009) Key aspects of analytical method validation and linearity evaluation. J Chromatogr B 877:2224-2234
3. Billecke SS, Kitzmiller LA, Northrup JJ, Whitesall SE, Kimoto M, Hinz AV, D'Alecy LG (2006) Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 291:H1788-H1796
4. Billecke SS, D'Alecy LG, Platel R, Whitesall SE, Jamerson KA, Perlman RL, Gadegbeku CA (2009) Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrol Dial Transplant 24:489-496
5. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310
6. Böhmer A, Großkopf H, Jordan J, Tsikas D (2012a) Human hemoglobin does not contain asymmetric dimethylarginine (ADMA). Nitric Oxide 27:72-74
7. Böhmer A, Beckmann B, Sandmann J, Tsikas D (2012b) Doubts concerning functional endothelial nitric oxide synthase in human erythrocytes. Blood 119:1322-1323
8. Bouteldja N, Woodman RJ, Hewitson CL, Domingo E, Barbara JA, Mangoni AA (2013) Methylated arginines and nitric oxide in end-stage renal disease: impact of inflammation, oxidative stress and haemodialysis. Biomarkers 18:357-364
9. Burkhardt O, Hafer C, Langhoff A, Kaever V, Kumar V, Welte T, Haller H, Fliser D, Kielstein JT (2009) Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant 24:267-271
10. D'Alecy LG, Billecke SS (2010) Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress. Blood Cells Mol Dis 45:40
11. Damoglou AP, Lindley H, Stapleton IW (1971) The hydrolysis by thermolysin of dipeptide derivatives that contain substituted cysteine. Biochem J 123:379-384
12. Davids M, van Hell AJ, Visser M, Nijveldt RJ, van Leeuwen PAM, Teerlink T (2012) Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am J Physiol Heart Circ Physiol 302:H1762-H1770
13. Davids M, Peters JHC, de Jong S, Teerlink T (2013) Measurement of nitric oxide-related amino acids in serum and plasma: effects of blood clotting and type of anticoagulant. Clin Chim Acta 421C:164-167
14. Eksborg S (1981) Evaluation of method-comparison data. Clin Chem 27:1311-1312
15. Ellmerer M, Schaupp L, Brunner GA, Sendlhofer G, Wutte A, Wach P, Pieber TR (2000) Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 278:E352-E356
16. Feder J, Garrett LR, Wildi BS (1971) Studies on the role of calcium in thermolysin. Biochemistry 10:4552-4556
17. Girg R, Rudolph R, Jaenicke R (1981) Limited proteolysis of porcine-muscle lactic dehydrogenase by thermolysin during reconstitution yields dimers. Eur J Biochem 119:301-305
18. Großkopf H, Böhmer A, Tsikas D (2012) Letter to the editor: "Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine". Am J Physiol Heart Circ Physiol 303:751-752
19. Horowitz JD, Heresztyn T (2007) An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B 851:42-50
20. Ikizler TA (2005) Effects of haemodialysis on protein metabolism. J Ren Nutr 15:39-43
21. Jenkins RE, Tanner JA (1977) The structure of the major protein of the human erythrocyte membrane. Characterization of the intact protein and major fragments. Biochem J 161:139-147
22. Kang ES, Cates TB, Harper DN, Chiang TM, Myers LK, Acchiardo SR, Kimoto M (2011) An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Free Rad Res 35:693-707
23. Karim AR, Rees WD, Holman GD (1987) Binding of cytochalasin B to trypsin and thermolysin fragments of the human erythrocyte hexose transporter. Biochim Biophys Acta 902:402-405
24. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594-600
25. Kielstein JT, Böger RH, Bode-Böger SM, Martens-Lobenhoffer J, Lonnemann G, Frölich JC, Haller H, Fliser D (2004) Low dialysance of asymmetric dimethylarginine (ADMA) - in vivo and in vitro evidence of significant protein binding. Clin Nephrol 62:295-300
26. Kielstein A, Tsikas D, Galloway GP, Mendelson JE (2007) Asymmetric dimethylarginine (ADMA) - a modulator of nociception in opiate tolerance and addiction? Nitric Oxide 17:55-59
27. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozüyaman B, Schnürch HG, Gödecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rösen P, Kelm M (2006) Red blood cells express a functional endothelial nitric oxide synthase. Blood 107:2943-2951
28. Komori Y, Nonogaki T, Nikai T (2001) Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39:1327-1332
29. Kramer E, Routh JI (1973) The binding of salicylic acid and acetylsalicylic acid to human serum albumin. Clin Biochem 6:98-105
30. Kurz H, Trunk H, Weitz B (1977) Evaluation of methods to determine protein-binding of drugs: equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneimittelforschung 27:1373-1380
31. Leiper JM, Vallance P (2006) The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 26:33-38
32. Lenzen H, Tsikas T, Böger RH (2006) Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease. The multicenter CARDIAC study. Eur J Clin Pharmacol 62:45-49
33. May M, Batkai S, Zörner AA, Tsikas D, Jordan J, Engeli S (2014) Clinical evaluation of extracellular ADMA concentrations in human blood and adipose tissue. Int J Mol Sci 15:1189-1200
34. May M, Kayacelebi AA, Batkai S, Jordan J, Tsikas D, Engeli S (2015) Plasma and tissue homoarginine concentrations in healthy and obese humans. Amino Acids. doi: 10.1007/s00726-015-1922-4
35. Morris ME, Levy G (1984) Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci 73:1038-1041
36. Oldham PD (1968) Measurement in medicine: the interpretation of numerical data. English Universities Press, London
37. Rifai K, Bode-Boeger SM, Martens-Lobenhoffer J, Ernst T, Kretschmer U, Hafer C, Fliser D, Manns MP, Kielstein JT (2010) Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption. Scand J Gastroenterol 45:1110-1115
38. Schepers E, Speer T, Bode-Böger SM, Fliser D, Kielstein JT (2014) Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? Semin Nephrol 34:97-105
39. Teerlink T (2007) HPLC analysis of ADMA and other methylated l-arginine analogs inn biological samples. J Chromatogr B 851:21-29
40. Trettin A, Modun D, Madunic S, Vukovic J, Radman M, Batkai S, Thum T, Jordan J, Tsikas D (2014) LC-MS/MS and GC-MS/MS measurement of plasma and urine di-paracetamol and 3-nitro-paracetamol: proof-of-concept studies on a novel human model of oxidative stress based on oral paracetamol administration. J Chromatogr B 959:71-81
41. Tsikas D (2007) Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine/nitric oxide area of research. J Chromatogr B 851:51-70
42. Tsikas D (2008) Determination of asymmetric dimethylarginine in biological fluids: a paradigm for a successful analytical story. Curr Opin Clin Nutr Metab Care 11:592-600
43. Tsikas D (2009) De novo synthesis of trideuteromethyl esters of amino acids for use in GC-MS and GC-tandem MS exemplified for ADMA in in human plasma and urine: standardization, validation, comparison and proof of evidence for their aptitude as internal standards. J Chromatogr B 877:2308-2320
44. Tsikas D, Beckmann B (2009) Albumin from human serum does not contain asymmetric dimethylarginine (ADMA). Clin Biochem 42:1739-1740
45. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Frölich JC (2000) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1-3
46. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Schwedhelm E, Frölich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798:87-99
47. Tsikas D, Engeli S, Beckmann B, Jordan J (2010) Asymmetric dimethylarginine (ADMA) is present in plasma proteins of healthy subjects at the low nmol-per-g-level. Nitric Oxide 22:316-317
48. Tsikas D, Böhmer A, Großkopf H, Beckmann B, Dreißigacker U, Jordan J, Maassen N (2012) Clinical-chemistry laboratory relevant hemolysis is unlikely to compromise human plasma concentration of free asymmetric dimethylarginine (ADMA). Clin Biochem 45:1536-1538
49. Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339(8793):572-575
50. Zinellu A, Sotgia S, Scanu B, Formato M, Deiana L, Carru C (2007) Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV detection. Electrophoresis 28:4452-4458
51. Zinellu A, Sotgia S, Scanu B, Deiana L, Carru C (2008) Determination of proteinincorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation. Clin Biochem 41:1218-1223